Article By RoboForex.com
Markets quickly befriended President Trump, closing in positive territory after initial heavy losses. Which sectors and stocks will profit from President Trump? One of the largest gaining sectors of Trump´s victory is the pharmaceutical and bio tech segment. Hillary Clinton had announced price capping for medicines, Trump refuses to do so. Pfizer, Amgen, Gilead and others profit from this vastly. Trump is looking to rejuvenate the US infrastructure, this will lead to higher employment and raise profits for the construction sector. The world´s largest plant machines producer Caterpillar belongs to those who profit. Donald Trump supports fossil fuels such as coal and oil, so also favoring companies who operate in this segment. The losers here being solar and environmental companies.
The DAX is in a sideways trend. Resistance is at 10820, support at 10250.
The Euro is in a large sideways trend against the Dollar. Support is at 1.0822, resistance at 1.1429.
The USD is in a midterm upward trend
Gold is in an upward trend
Free Reports:
WTI Oil is in a downward trend
The election jitters in the USA have passed, markets quickly returned to normality. After initial heavy losses, stocks managed to close positively. The DAX gained 1.56%. Largest gaining stocks in the DAX index were in the medical and pharmaceutical sector. Hillary Clinton´s price controls won´t be enforced under Trump. As such, this segment was the most sought on Wall Street. The pharmacy-heavyweight Pfizer gained 7.07%. The world´s largest construction machine producer CAT gained 7.7%. JP Morgan and Goldman Sachs also profited from Trump´s victory. Asian markets are very firm this morning. The Nikkei 225 gains 6.05%. The USD trades weaker, whilst Gold rises. WTI Oil is unchanged.
RoboForex Analytical Department
Article By RoboForex.com
Attention!
Forecasts presented in this section only reflect the author’s private opinion and should not be considered as guidance for trading. RoboForex LP bears no responsibility for trading results based on trading recommendations described in these analytical reviews.